Decreased levels of Glo-1 and increased intracellular dicarbonyl stress occurs in liver fibrosis, cirrhosis, non-alcoholic steatohepatitis (NASH) and hepatocellular carcinoma. The gene discussed is GLO1; the disease is metabolic dysfunction-associated steatohepatitis.